Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Some common medications can harm male fertility, but many effects can be reversed.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Condensed nanofat with fat grafts effectively improves atrophic facial scars.